Alnylam Completes Enrollment in Phase IIb Study of ALN-RSV01, an RNAi ... MarketWatch (press release) ... in the US RSV infection in lung transplant patients represents an important unmet medical need; the condition is associated with significant morbidity, including the development of acute lung transplant rejection in up to 20% of infected patients. ... |
